Bioster, a.s.
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Traumacel PULVIS and Traumacel ENDO Applicator in the Post-market Surveillance Phase (NCT05177887) | Bioster, a.s. | 2022-02-01 |
| Traumacel FAM Trium in the Post-market Surveillance Phase (NCT05177874) | Bioster, a.s. | 2020-05-18 |
Track Bioster, a.s. automatically
Every clearance here is in the API, with alerts when new ones post.